8:00 am Conference Registration & Welcome Coffee

8:50 am Chair’s Opening Remarks

Demonstrating the Value of Digital Therapeutics To Payors, Doctors & Patients

9:00 am Panel Discussion: Achieving Buy-in & Adoption from Payors for Digital Therapeutics to Enable Commercial Expansion

Synopsis

  • Discussing strategies to convey the value proposition and benefits of digital therapeutics to stakeholders
  • Debating the current reservations from payors and how to address them
  • Improving collaboration with payors to maximize the adaption of digital therapeutics

9:45 am Easing the Healthcare Worker Shortage Through Digital Therapeutics to Treat Tobacco Addiction

Synopsis

  • Leveraging digital therapeutics to treat tobacco addiction to ease healthcare
  • Creating a successful treatment of tobacco dependence to enhance every other digital program and bend the arc of morbidity and mortality
  • Designing the correct marketing and messaging to enable high commercial return for successfully treating tobacco users

10:15 am Morning Break & Structured Networking

11:15 am Leveraging Digital Therapeutics to Improve Patient Experience

  • Alyssa Dietz Sr. Director, Strategic Planning & Operations, Twill

Synopsis

  • Improving access to mental health services through immediate tools
  • Finding the appropriate fit for patients
  • Broadening services to healthcare providers to improve patient experience

11:45 am Effectively Targeting Clinicians & Patients to Ensure Digital Therapeutics are the Right Fit for Patients

Synopsis

  • Hearing the patient voice and understanding the features they want to see in a digital therapeutic
  • Building trust with patients to increase digital therapeutic adoption
  • Increasing clinician and patient involvement through the whole life cycle to create a product that is fully patient-centric

12:15 pm Networking Lunch

1:15 pm Panel Discussion: Understanding Patient’s & Doctor’s Perspectives on Digital Therapeutics to Increase Adoption

Synopsis

  • Questioning the current reservations from patients and doctors and how to address them
  • Examining the early adopters and prescribers of DTx to see how products can be improved
  • Successfully demonstrating and conveying the value proposition and benefits of DTx to patients: evidence needed to drive adoption

Creating Effective Partnerships with Pharmaceutical Companies

2:00 pm Panel Discussion: Creating Strong Mutually-Beneficial Working Relationships with Digital Therapeutic Partners

Synopsis

  • Finalizing financial details with partnerships
  • Adapting the infrastructure within both teams to digital to enable success
  • Exploring how pharma and DTx are commercializing together to influence opportunities and overcome pain points

2:45 pm Afternoon Coffee & Networking

3:45 pm Optimizing Usage of Data to Generate Effectiveness and Efficacy Evidence

  • Brendon Hale VP, Health & Market Outcomes Research, Penumbra

Synopsis

  • Conquering evidence generation with system generated data, patient reported outcomes, and established clinical assessments
  • Effectively using data to assess patient engagement
  • Finding and incorporating the most suitable technologies to streamline data generation

4:15 pm Chair’s Closing Remarks and End of Conference Day One